Cargando…
PTEN Loss is Associated with Upgrading of Prostate Cancer from Biopsy to Radical Prostatectomy
When distinguishing between indolent and potentially harmful prostate cancers, the Gleason score is the most important variable, but may be inaccurate in biopsies due to tumor under-sampling. This study investigated whether a molecular feature, PTEN protein loss, could help identify which Gleason sc...
Autores principales: | Lotan, Tamara L., Carvalho, Filipe LF., Peskoe, Sarah B., Hicks, Jessica L., Good, Jennifer, Fedor, Helen, Humphreys, Elizabeth, Han, Misop, Platz, Elizabeth A., Squire, Jeremy A., De Marzo, Angelo M., Berman, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282985/ https://www.ncbi.nlm.nih.gov/pubmed/24993522 http://dx.doi.org/10.1038/modpathol.2014.85 |
Ejemplares similares
-
PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
por: Lotan, Tamara L., et al.
Publicado: (2017) -
The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy
por: Heaphy, Christopher M, et al.
Publicado: (2022) -
PTEN Status Assessment in the Johns Hopkins Active Surveillance Cohort
por: Tosoian, Jeffrey J., et al.
Publicado: (2018) -
Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy
por: Faraj, Sheila F., et al.
Publicado: (2016) -
Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion
por: Gumuskaya, Berrak, et al.
Publicado: (2013)